Description:
CHOROIDEREMIA; CHM
CHM GENE; CHM
|
Repository
|
No Data
|
| Subcollection |
Heritable Diseases
PIGI Consented Sample |
|
License Required
|
No Data
|
|
Sample Source
|
No Data
|
|
Subject Type
|
No Data
|
|
Family Type
|
No Data
|
|
Ethnicity
|
No Data
|
|
Family Member
|
No Data
|
|
Genetic Data
|
No Data
|
| PDL at Freeze |
5.88 |
| Passage Frozen |
3 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Gene |
CHM |
| Chromosomal Location |
Xq21.2 |
| Allelic Variant 1 |
p.R270X; CHOROIDEREMIA |
| Identified Mutation |
ARG270TER |
| |
| Gene |
CHM |
| Chromosomal Location |
Xq21.2 |
| Allelic Variant 1 |
; CHOROIDEREMIA |
| Identified Mutation |
c.116+215insCCTTT |
| |
| Gene |
CHM |
| Chromosomal Location |
Xq21.2 |
| Allelic Variant 1 |
; CHOROIDEREMIA |
| Identified Mutation |
c.116+80C>T |
| Sarkar H, Mitsios A, Smart M, Skinner J, Welch A, Kalatzis V, Coffey P, Dubis AM, Webster A, Moosajee M, Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics Human molecular genetics: 2019 |
| PubMed ID: 30689859 |
| Cumulative PDL at Freeze |
5.88 |
| Passage Frozen |
3 |
| Split Ratio |
1:2 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
3% |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Supplement |
- |
|